These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3839406

  • 1. Histogenesis of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW, Weisbrode SE.
    Bone; 1985; 6(2):105-12. PubMed ID: 3839406
    [Abstract] [Full Text] [Related]

  • 2. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW, Weisbrode SE.
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [Abstract] [Full Text] [Related]

  • 3. Ultrastructural development of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW, Weisbrode SE, Kindig O.
    Bone; 1985 Jun; 6(3):165-72. PubMed ID: 3839678
    [Abstract] [Full Text] [Related]

  • 4. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.
    Lindgren JU, Johnell O, DeLuca HF.
    Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979
    [Abstract] [Full Text] [Related]

  • 5. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 6. Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats fed a low-calcium diet.
    Weisbrode SE, Capen CC, Norman AW.
    Am J Pathol; 1978 Aug; 92(2):459-72. PubMed ID: 677270
    [Abstract] [Full Text] [Related]

  • 7. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
    Armbrecht HJ, Zenser TV, Davis BB.
    Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
    [Abstract] [Full Text] [Related]

  • 8. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC, Norman AW.
    Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
    [Abstract] [Full Text] [Related]

  • 9. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG.
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [Abstract] [Full Text] [Related]

  • 10. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ, Hott M, Garba MT.
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [Abstract] [Full Text] [Related]

  • 11. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG, Baylink DJ, Sherrard DJ.
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [Abstract] [Full Text] [Related]

  • 12. The effects of the major vitamin D metabolites upon the resolution of osteomalacia in uremic adult rats.
    Lieuallen WG, Weisbrode SE, Horst RL.
    Bone; 1990 Mar; 11(4):267-73. PubMed ID: 2242292
    [Abstract] [Full Text] [Related]

  • 13. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ, Travers R.
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [Abstract] [Full Text] [Related]

  • 14. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH.
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [Abstract] [Full Text] [Related]

  • 15. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA, Beneton M, Harvey L, Lawson DE.
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [Abstract] [Full Text] [Related]

  • 16. Effects of 1,25-dihydroxicolecalciferol and dietary calcium-phosphate on distribution of lead to tissues during growth.
    Cortina-Ramírez GE, Cerbón-Solorzano J, Calderón-Salinas JV.
    Toxicol Appl Pharmacol; 2006 Jan 01; 210(1-2):123-7. PubMed ID: 16223518
    [Abstract] [Full Text] [Related]

  • 17. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ, Hott M, Garba MT.
    Metabolism; 1985 Aug 01; 34(8):777-83. PubMed ID: 3839559
    [Abstract] [Full Text] [Related]

  • 18. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet.
    Goulding A, Gold E, Fisher L.
    Bone Miner; 1990 Mar 01; 8(3):185-93. PubMed ID: 2322693
    [Abstract] [Full Text] [Related]

  • 19. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
    High WB, Capen CC, Black HE.
    Am J Pathol; 1981 Dec 01; 105(3):279-87. PubMed ID: 6895577
    [Abstract] [Full Text] [Related]

  • 20. [Effects of local application of 1,25 (OH)2D3 on experimental tooth movement in rats].
    Kawakami M.
    Osaka Daigaku Shigaku Zasshi; 1990 Jun 01; 35(1):128-46. PubMed ID: 2135402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.